APA

Robert-Richard E., Moreau-Gaudry F., Lalanne M., Lamrissi-Garcia I., Cario-André M., Guyonnet-Dupérat V., Taine L., Ged C. & de Verneuil H. (20080130). Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cells. : American journal of human genetics.

Chicago

Robert-Richard Elodie, Moreau-Gaudry François, Lalanne Magalie, Lamrissi-Garcia Isabelle, Cario-André Muriel, Guyonnet-Dupérat Véronique, Taine Laurence, Ged Cécile and de Verneuil Hubert. 20080130. Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cells. : American journal of human genetics.

Harvard

Robert-Richard E., Moreau-Gaudry F., Lalanne M., Lamrissi-Garcia I., Cario-André M., Guyonnet-Dupérat V., Taine L., Ged C. and de Verneuil H. (20080130). Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cells. : American journal of human genetics.

MLA

Robert-Richard Elodie, Moreau-Gaudry François, Lalanne Magalie, Lamrissi-Garcia Isabelle, Cario-André Muriel, Guyonnet-Dupérat Véronique, Taine Laurence, Ged Cécile and de Verneuil Hubert. Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cells. : American journal of human genetics. 20080130.